Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00112268 · ClinicalTrials.gov registry record · Phase 3
Quitlink : A Leveraging Solution to Tobacco Counseling
A Phase 3 study of Smoking, sponsored by Virginia Ambulatory Care Outcomes Research Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,200
- Enrollment target
- 1
- Study location
NCT00112268 is a Phase 3 study of Smoking that has completed, run by Virginia Ambulatory Care Outcomes Research Network. The registered enrollment target is 3,200 participants, above the 429-participant average among 123 other Smoking trials with a reported enrollment target (646% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00112268, a Phase 3 study of Smoking, has completed, sponsored by Virginia Ambulatory Care Outcomes Research Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,200 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary: To test whether the delivery of A3-5 smoking cessation counseling (Assess, Assist, Arrange) in primary care offices is enhanced by a system that couples (1) an expanded vital sign intervention with (2) fax referral of preparation-stage patients for telephone counseling and (3) feedback to the provider. The question will be examined in a randomized trial, with practices as the unit of analysis and with a control intervention consisting of a conventional vital sign intervention. The experiment will therefore compare what intervention and control practices accomplish beyond simply identifying patients who use tobacco. Secondary: To assess contextual factors that might affect implementation of the intervention and account for its ultimate success or failure. In particular, to assess: (1) environmental and practice-level factors that affect practices' ability to successfully implement and use the intervention and; (2) patient characteristics beyond readiness to change (i.e., age, gender, race/ethnicity) that affect willingness to use the quit line and complete counseling.
Conditions Studied
Interventions
- BEHAVIORAL QuitLink (office support system for quit line referral)
Study Locations (1)
Virginia
- Virginia Ambulatory Care Outcomes Network (ACORN) - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,200 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00112268
The ClinicalTrials.gov registry entry for NCT00112268 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 429-participant average among 123 other Smoking trials with a reported enrollment target (646% higher). The listed sponsor is Virginia Ambulatory Care Outcomes Research Network, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which QuitLink (office support system for quit line referral) is the first listed.
NCT00112268 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00112268 about?
NCT00112268 is a clinical study titled "Quitlink : A Leveraging Solution to Tobacco Counseling". Primary: To test whether the delivery of A3-5 smoking cessation counseling (Assess, Assist, Arrange) in primary care offices is enhanced by a system that couples (1) an expanded vital sign intervention with (2) fax referral of preparation-stage patients for telephone counseling and (3) feedback to t...
What is the current status of trial NCT00112268?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,200 participants. The study started on 2005-06. Estimated completion is 2006-07.
What conditions does trial NCT00112268 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT00112268?
The interventions under investigation include: QuitLink (office support system for quit line referral) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00112268?
This trial is sponsored by Virginia Ambulatory Care Outcomes Research Network, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00112268 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integrating Financial Coaching and Smoking Cessation Coaching
RECRUITING · Phase 3
-
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Tobacco Tactics Website for Operating Engineers
COMPLETED · Phase 3
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.